A comprehensive search of the literature was conducted to identify studies evaluating the impact of GBA (glucocerebrosidase) gene variants on clinical outcomes following deep brain stimulation (DBS) in Parkinson’s disease. The gene discussed is GBA1; the disease is Parkinson disease.